ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Field of Research : Central Nervous System
Research Topic : geriatrics
Clear All
Filter by Field of Research
Central Nervous System (2)
Clinical Sciences (1)
Geriatrics And Gerontology (1)
Geriatrics and Gerontology (1)
Neurosciences (1)
Pathology (1)
Psychiatry (incl. Psychotherapy) (1)
Filter by Socio-Economic Objective
Health related to ageing (1)
Mental Health (1)
Nervous system and disorders (1)
Neurodegenerative Disorders Related to Ageing (1)
Filter by Funding Provider
Australian Research Council (2)
Filter by Status
Closed (2)
Filter by Scheme
Discovery Projects (1)
Linkage Projects (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
NSW (1)
WA (1)
  • Researchers (3)
  • Funded Activities (2)
  • Organisations (14)
  • Funded Activity

    Linkage Projects - Grant ID: LP0209081

    Funder
    Australian Research Council
    Funding Amount
    $199,980.00
    Summary
    How critical is the inflammatory response in senile plaque formation in a mutant APP transgenic mouse model? The aims of this project is to examine the brains of mice genetically engineered to produce a human mutant form of insoluble beta amyloid protein known to play a critical role in the development of Alzheimer's disease (AD). If the "trigger" for AD is an inflammatory reaction, then the relevant examination of the early stages of senile plaque formation in these animals could lead to pharma .... How critical is the inflammatory response in senile plaque formation in a mutant APP transgenic mouse model? The aims of this project is to examine the brains of mice genetically engineered to produce a human mutant form of insoluble beta amyloid protein known to play a critical role in the development of Alzheimer's disease (AD). If the "trigger" for AD is an inflammatory reaction, then the relevant examination of the early stages of senile plaque formation in these animals could lead to pharmaceutical intervention to delay the development of this debilitating disease. A 5 year delay would significantly reduce the number of people with AD, not only adding years of improved quality of life, but also saving hundreds of millions of Australian dollars in health costs.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP120102078

    Funder
    Australian Research Council
    Funding Amount
    $330,000.00
    Summary
    Plasma protein profiles in normal brain ageing and early stages of dementia. Brain changes related to ageing and dementia are associated with altered proteins that can be detected in the blood. This project will examine blood samples from a number of well-characterised ageing cohorts to discover proteins that may serve as potential markers of brain ageing and the early stages of dementia.
    More information

    Showing 1-2 of 2 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback